FDA Inspection 985381 — Genzyme Corporation

Genzyme Corporation — FEI 3009389940

The FDA completed an inspection of Genzyme Corporation on August 18, 2016 in Northborough, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 18, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Northborough, MA (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
360221 CFR 211.160(a)Deviations from laboratory control requirements
457621 CFR 211.192No written record of investigation